A reminder on physiology: this class of drug acts on the gastric parietal cells by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system (the H+/K+ ATPase, aka the gastric proton pump), hence the elegant name
4/ Do they work? YES THEY DO!
They are great meds and essential for:
1⃣ Erosive esophagitis / Barrett's
2⃣ Peptic ulcer / prophylaxis for pts taking NSAIDs/aspirin / ZE
3⃣ H. pylori eradication
They are also prescribed for symptoms such as non-erosive reflux +/- dyspepsia
5/ The AspECT trial in @TheLancet showed that a chemoprevention strategy of aspirin + high dose #PPI offered the best event-free survival in patients with Barrett's
7/
As for prophylaxis, our Dean Prof @FrancisKLChan@CUHKMedicine led a RCT in @NEJM of pts with Hx of #UGIB + H pylori infection + low dose aspirin or NSAIDs, showing that prophylaxis with PPI is better than eradication alone in preventing recurrent bleeding for NSAIDs
8/ How about H pylori infection?
From the latest Maastricht V/Florence, Toronto & AP consensus, most if not all eradication regimens contain PPIs
Being one of the most frequently prescribed 💊around the🌏, my take is that PPIs are largely safe
The problem actually stems from its relative safety. Many a time they are prescribed far too carefree and liberally
A discussion below:
11/ These are some of the reported adverse events associated with long term PPI use with their proposed mechanisms from a great review by Vaezi et al. @AGA_Gastro@AmerGastroAssn
12/ This is all very scary, but what are the effect sizes?
Another excellent review by @UofT_GI_Head in @AmJGastro@AmCollegeGastro summarizes some of the recent estimates
- Enteric infections OR 2.55
- Other reported associations effect size < 2
13/ @UofT_GI_Head also did a robust study that refuted the causal association between PPI use and fractures with no differences shown using BMD, markers of bone metabolism or measures of bone strength for PPI users
14/ Recently, several observational studies have reported a⬆️risk of stomach cancer in long term PPI users, summarized expertly here:
📌likely limited to pts with current or past Hx of HP
📌probably already had underlying precancerous lesions
But PPIs may interfere with this which led to FDA drug label change for clopidogrel
(dex)lansoprazole & pantoprazole have less effect on this
16/ A brief recap:
✅PPIs are great, effective and largely safe!
⚠️Though there are some safety signals
- Infections: enteric, C. difficile, pneumonia
- GI: fundic gland polyps, ⬆️CA stomach
- Micronutrient ⬇️
- Dementia
- Renal failure
- Drug-drug interactions with clopidogrel
17/ We should stop PPIs if not indicated/helping!
🦪from @UofT_GI_Head on deprescribing PPIs:
🔭look out for rebound gastric acid hypersecretion
🧠mindful of rebound symptoms
🗓️take PPIs every other day for 2 weeks, 2x/week for 2 weeks, then stop
18/ In some circumstances H2RA can perform quite well too
Though pts on low-dose aspirin (LDA) + PPI had a slightly lower proportion of recurrent bleeding or ulcer compared with H2RA this was not statistically significant in this study
🤔Reasonable to switch to LDA + H2RA?
19/ To conclude, good practice when prescribing PPIs:
- Discuss on indications and potential SEs
- ⚖️risks and benefits
- Consider🔁acid suppressants
- ⬇️possible dose to control symptoms
- 🛑Deprescribe PPIs, not just abruptly stop them
This is defined as a bleeding source proximal to the Ligament of Treitz, also known as the suspensory muscle of duodenum, the landmark that separates the duodenum & jejunum
3/ Back to PUD, there are actually many well established causes and some associated factors related to its development, the most important being:
💊 Drugs - NSAIDs/aspirin, direct chemical/erosive agents etc
🦠 Bugs - H. pylori
♋ Thugs (if I may) - Neoplasm
Let's start with a poll followed by a #tweetorial on direct oral anticoagulants. First things first, which is your go-to choice of #DOAC ? (COI: none):
2/ These agents work "directly" to anti-coagulate and since they are hardly "new' anymore the term #NOAC has become obsolete. Dabigatran is a direct thrombin inhibitor (factor IIa), whereas the others are factor Xa inhibitors (note the Xa in their names)
3/ In general they share many characteristics such as a quick onset of action, shorter half-lives, potential for drug-drug interactions (CYP3A4 & P-gp) and renal elimination (except apixaban) when compared with warfarin
1/
Sharing of measures observed at my institution in #HongKong currently in place for #COVID19 and some personal practice I have adopted, not exhaustive:
2/ Departmental 1. Cut all elective cases (only GI bleeds, cholangitis, OJ left; cancer cases reviewed case-by-case) 2. FTOCC +ve should be deferred if possible 3. Full PPE (hair net, face shield/goggles, N95, gowns, gloves etc) as appropriate per local guidance
3/ 4. Extended use of N95, but not reuse (changing is protecting patients more than healthcare staff; if you take it off you shouldn't put the same one back on) 5. Scopes done by senior/independent endoscopists; no more training to reduce staff risk exposure and preserve PPE